Source: Lucy Nicholson/Reuters
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Australia’s doctors are pushing for more clinics to speed up the country’s lagging COVID-19 vaccine program — a strategy they say would be more effective than creating mass inoculation hubs
  • The Australian Medical Association (AMA) said on Thursday that larger centres would pose “huge logistical challenges”
  • Prime Minister Scott Morrison said the mass centres would start vaccinating those aged over 50 from as early as June
  • As of Wednesday, roughly 1.36 million doses have been administered — far short of the four million that had been targeted by the end of March
  • Nevertheless, Australia has fared much better than many other developed countries, with just over 29,400 confirmed cases and 910 deaths

Australia’s doctors are pushing for more clinics to speed up the country’s lagging COVID-19 vaccine program — a strategy they say would be more effective than creating mass inoculation hubs.

Omar Khorshid, President of the Australian Medical Association (AMA) said on Thursday that larger centres would pose “huge logistical challenges,” including difficulties in finding enough medical staff to manage the facilities.

“You need to find a workforce from somewhere, and we are not aware of large numbers of registered nurses and doctors who are available to manage these centres,” he told ABC Radio.

Prime Minister Scott Morrison said on Wednesday that he would discuss setting up the centres with state and territory leaders, which would vaccinate those aged over 50 from as early as June.

Morrison has been under growing pressure to get Australia’s vaccine rollout back on track after problems caused partly by supply issues and changing medical advice led to major delays.

Earlier this week he abandoned a target to provide at least one vaccine dose to all Australians — some 26 million people — by the end of the year.

Reports from Europe’s drug regulator of rare cases of blood clots among some recipients of the AstraZeneca vaccine proved to be a massive blow to Australia, which had hoped to locally produce 50 million doses.

As a result, health officials have been forced to review their strategy, which included doubling a previous order of Pfizer vaccines to 40 million.

Khorshid said it made sense to delay the creation of mass vaccination hubs until bulk deliveries of the Pfizer vaccine were received.

Morrison, who has reinstated twice weekly meetings of the national cabinet tasked with tackling the pandemic, said he would consider the AMA’s suggestions.

As of Wednesday, roughly 1.36 million doses have been administered — far short of the four million that had been targeted by the end of March.

Nevertheless, Australia has fared much better than many other developed countries during the pandemic, with just over 29,400 confirmed cases and 910 deaths.

That compares with roughly 4.38 million cases and 127,000 deaths in the United Kingdom and around 31.4 million cases and 564,000 deaths in the United States.

More From The Market Online
AI concept

The great AI scare sell-off is still permeating Wall Street; a speculative blog from the not-so-distant future stands as the latest culprit

The ongoing tech sell-off in the United States, ironically driven by the larger AI thematic itself, continues to define
US and Aus flag

The XJO benefitted from geopolitical calm last week. New tariff fears perhaps feel more familiar

Last week, I wrote that the ASX200 was having a good week, where Australian investors were reacting to Australian earnings reports and how

Okay, so just where is gold heading? Experts say its nowhere near finishline yet

Leading industry, government and investment groups are still confident that the gold’s bull run is nowhere…
Koala share trading AI

The ASX 200 is up over 4% YTD. What EOY targets are floating around?

It’s been a pretty good year for the ASX200 so far, helped greatly by the ‘commodity supercycle’ narrative – which isn’t really a